RWE 101 – Regulatory Intelligence
In the context of real-world evidence (RWE) and real-world research (RWR), regulatory intelligence refers to the process of gathering, analyzing, and interpreting regulatory information from various sources to support compliance with regulatory requirements and inform decision-making.
Regulatory intelligence can help stakeholders in the healthcare industry, such as pharmaceutical companies, medical device manufacturers, and healthcare providers, to understand and navigate the complex and ever-changing regulatory landscape. It involves tracking and analyzing regulatory developments, including new and updated regulations, guidance documents, and policies, as well as monitoring regulatory enforcement actions, such as warning letters and product recalls.
By staying up-to-date with regulatory requirements and trends, stakeholders can better assess the potential regulatory implications of RWE and RWR studies, ensure compliance with relevant regulations, and make informed decisions about product development, clinical trials, and post-market surveillance.
In short…regulatory intelligence is a critical component of RWE and RWR that helps ensure that stakeholders are aware of and able to comply with regulatory requirements in their respective fields.
Share this story...
Real World Evidence (RWE) 101 – Registry vs Registry-Based Study
RWE 101 - Registry vs Registry-Based Study In the context of real-world evidence, a registry is a collection of data on a particular disease, medical condition, or [...]
Real World Evidence (RWE) 101 – Pregnancy Registries
RWE 101 - Pregnancy Registries A pregnancy registry is a type of real-world evidence collection system that collects data from pregnant women who have been exposed to [...]
Real World Evidence (RWE) 101 – Diversity
RWE 101 - Diversity Diversity in the context of real-world research refers to the inclusion of individuals from different backgrounds, including but not limited to race, ethnicity, gender, [...]
Real World Evidence (RWE) 101 – The Patient Voice
RWE 101 - The Patient Voice The patient voice refers to the perspectives, opinions, and experiences of patients and their families or caregivers in the context of [...]
Real World Evidence (RWE) 101 – ISPE GPP
RWE 101 - ISPE GPP The International Society of Pharmacoepidemiology (ISPE) Good Pharmacoepidemiology Practices (GPP) provides guidance for the conduct and reporting of pharmacoepidemiologic studies. The key [...]
Real World Evidence (RWE) 101 – EMA Good Pharmacovigilance Practices (GVPs)
RWE 101 - EMA Good Pharmacovigilance Practices (GVPs) The European Medicines Agency's (EMA) Good Pharmacovigilance Practices (GVPs) provide a framework for the monitoring and reporting of adverse drug [...]
